Evidence map›Paper›PMID 24423935›Full record

ArticleMenopause (New York, N.Y.)2014

Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.

Jennie K Kline, Ann M Kinney, Bruce Levin, Stephen A Brown, Andrew G Hadd, Dorothy Warburton

Abstract read
In one paragraph

Article in Menopause (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. FMR1 genotype interacts with parenting stress to shape health and functional abilities in older age.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Trial
  2. Article
  3. IsFrontiers in psychiatry · 2021
    Article
  4. Article
  5. Article
  6. Expanded alleles of theBioscience reports · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennie K KlineFrom the 1Imprints Center, New York State Psychiatric Institute, New York, NY; 2Department of Epidemiology, 3Gertrude H. Sergievsky Center, and 4Department of Biostatistics, Columbia University, New York, NY; 5Department of Obstetrics, Gynecology, and Reproductive Science, The University of Vermont, Burlington, VT; 6Diagnostic Research and Technology Development, Asuragen Inc, Austin, TX; and 7Departments of Genetics and Development and Pediatrics, Columbia University, New York, NY.
Ann M Kinney
Bruce Levin
Stephen A Brown
Andrew G Hadd
Dorothy Warburton

Funding

Skewed X Inactivation and Reproductive LossR01HD042745 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WARBURTON, DOROTHY P. · 2002 to 2006
$2.3M
Technologies for Mapping Interspersed AGG Sequences in the FMR1 GeneR44HD066953 · NICHD · ASURAGEN, INC. · PI CHEN, LIANGJING CHEN · 2011 to 2012
$1.3M
EPIDEMIOLOGY OF TRISOMY AND OVARIAN AGER01AG015386 · NIA · NEW YORK STATE PSYCHIATRIC INSTITUTE · PI KLINE, JENNIE KATHERINE · 1998 to 2003
$1.2M
Trisomy and ovarian age: An epidemiologic studyR01HD053814 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KLINE, JENNIE KATHERINE · 2008 to 2010
$1.0M
Amplification Strategies for Detection of Fragile X Trinucleotide RepeatsR43HD060450 · NICHD · AMBION DIAGNOSTICS, INC. · PI HADD, ANDREW G · 2009 to 2009
$414k
Intramural NIH HHSNIA NIH HHS R01 AG015386NIA NIH HHS R01 AG 15386NICHD NIH HHS R01 HD042745NICHD NIH HHS R01 HD053814NICHD NIH HHS R01 HD 053814-01A2NICHD NIH HHS R01 HD 42725NICHD NIH HHS R43 HD060450NICHD NIH HHS R44 HD066953
6 · The paper itself

Abstract

objectivePremutation and intermediate CGG repeat length at the fragile X mental retardation 1 (FMR1) locus have been associated with premature ovarian failure. We tested whether intermediate length is associated with indicators of ovarian age in a sample of fertile women. Our primary measures of ovarian age were antimüllerian hormone (AMH) and follicle-stimulating hormone (FSH) levels.

methodsThe cross-sectional sample comprised 258 women with karyotyped spontaneous abortions (140 trisomic spontaneous abortions and 118 chromosomally normal spontaneous abortions or spontaneous abortions with anomalies other than trisomy) and 325 women with recent live births (LBs). We analyzed data from the total sample and data from LBs only. We defined CGG repeat length by the length (both continuous and categorical) on the longer allele.

resultsCGG repeat length was not significantly associated with either hormone measure. A repeat length of 35 to 54 CGG, versus the modal category of 30 CGG, was associated with an approximately 7% increase in median AMH level and a 3% increase in median FSH level. Results were unaltered when analyses were limited to LBs. Analyses of hormone levels using cutpoints to define older ovarian age showed no associations with repeat length. Among 10 women with repeat lengths of 35 to 54 CGG analyzed for AGG sequences, the uninterrupted CGG length was not significantly longer among women with hormonal indicators of "old" versus "young" ovarian age.

conclusionsOur data do not support an association between intermediate CGG repeat length and levels of AMH or FSH among fertile women.

Indexed as

Trinucleotide Repeat ExpansionAbortion, SpontaneousAdultAllelesAnti-Mullerian HormoneChromosome MappingFemaleFollicle Stimulating HormoneFragile X Messenger Ribonucleoprotein 1GenotypeHumansMutationPregnancyPrimary Ovarian InsufficiencyTrisomyYoung AdultAnti-Mullerian HormoneFMR1 protein, humanFollicle Stimulating HormoneFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID24423935
PMCPMC4065625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.